Engineering immunity in the mucosal niche against sexually transmitted infections
Identifieur interne : 001D28 ( Istex/Corpus ); précédent : 001D27; suivant : 001D29Engineering immunity in the mucosal niche against sexually transmitted infections
Auteurs : Renuka Ramanathan ; Kim WoodrowSource :
- Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology [ 1939-5116 ] ; 2016-01.
Abstract
The mucosal surfaces of the genital tract are the site of entry to over 30 different bacterial, parasitic, and viral pathogens that are the cause of sexually transmitted infections (STIs) including HIV. Women and adolescent girls are more severely impacted by STIs than men due in part to a greater biological susceptibility for acquiring infections and differences in disease sequelae. While it is widely accepted that preventative vaccines against the most commonly transmitted STIs would have a major impact on decreasing the global health burden of STIs for women worldwide, several challenges preclude their development. The female genital tract is a complex niche of microflora, hormonal influences, and immune tissues and cells that result in a mucosal immune system that is distinct from other mucosal sites and from our systemic immune system. An appreciation of these differences and their effect on shaping mucosal immunity to sexually transmitted pathogens is an important determinant for the design of effective STI vaccines. Here we describe the anatomy and mucosal immune system of the female reproductive tract, and discuss bioengineering strategies to design mucosal vaccines that overcome delivery challenges and coordinate the presentation kinetics and compartmentalization of antigens and adjuvants to relevant mucosal immune cell subsets. In particular, we describe recent progress in understanding the role of specific mucosal dendritic cell subsets in facilitating immune responses to pathogenic microbes in the genital mucosa. We also discuss the development of pathogen‐mimicking materials that may be useful for engineering protective immunity in this mucosal niche. WIREs Nanomed Nanobiotechnol 2015, 8:107–122. doi: 10.1002/wnan.1359 For further resources related to this article, please visit the WIREs website.
Url:
DOI: 10.1002/wnan.1359
Links to Exploration step
ISTEX:72A9720C0E2D5A684AC4D6A6A7B7A7FB8DC701DELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Engineering immunity in the mucosal niche against sexually transmitted infections</title><author><name sortKey="Ramanathan, Renuka" sort="Ramanathan, Renuka" uniqKey="Ramanathan R" first="Renuka" last="Ramanathan">Renuka Ramanathan</name><affiliation><mods:affiliation>Department of Bioengineering, University of Washington, WA, Seattle, USA</mods:affiliation></affiliation></author><author><name sortKey="Woodrow, Kim" sort="Woodrow, Kim" uniqKey="Woodrow K" first="Kim" last="Woodrow">Kim Woodrow</name><affiliation><mods:affiliation>Department of Bioengineering, University of Washington, WA, Seattle, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: woodrow@uw.edu</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:72A9720C0E2D5A684AC4D6A6A7B7A7FB8DC701DE</idno><date when="2016" year="2016">2016</date><idno type="doi">10.1002/wnan.1359</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-QT8G269T-H/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001D28</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001D28</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Engineering immunity in the mucosal niche against sexually transmitted infections</title><author><name sortKey="Ramanathan, Renuka" sort="Ramanathan, Renuka" uniqKey="Ramanathan R" first="Renuka" last="Ramanathan">Renuka Ramanathan</name><affiliation><mods:affiliation>Department of Bioengineering, University of Washington, WA, Seattle, USA</mods:affiliation></affiliation></author><author><name sortKey="Woodrow, Kim" sort="Woodrow, Kim" uniqKey="Woodrow K" first="Kim" last="Woodrow">Kim Woodrow</name><affiliation><mods:affiliation>Department of Bioengineering, University of Washington, WA, Seattle, USA</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: woodrow@uw.edu</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><title level="j" type="alt">WILEY INTERDISCIPLINARY REVIEWS: NANOMEDICINE AND NANOBIOTECHNOLOGY</title><idno type="ISSN">1939-5116</idno><idno type="eISSN">1939-0041</idno><imprint><biblScope unit="vol">8</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="107">107</biblScope><biblScope unit="page" to="122">122</biblScope><biblScope unit="page-count">16</biblScope><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>Hoboken, USA</pubPlace><date type="published" when="2016-01">2016-01</date></imprint><idno type="ISSN">1939-5116</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1939-5116</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">The mucosal surfaces of the genital tract are the site of entry to over 30 different bacterial, parasitic, and viral pathogens that are the cause of sexually transmitted infections (STIs) including HIV. Women and adolescent girls are more severely impacted by STIs than men due in part to a greater biological susceptibility for acquiring infections and differences in disease sequelae. While it is widely accepted that preventative vaccines against the most commonly transmitted STIs would have a major impact on decreasing the global health burden of STIs for women worldwide, several challenges preclude their development. The female genital tract is a complex niche of microflora, hormonal influences, and immune tissues and cells that result in a mucosal immune system that is distinct from other mucosal sites and from our systemic immune system. An appreciation of these differences and their effect on shaping mucosal immunity to sexually transmitted pathogens is an important determinant for the design of effective STI vaccines. Here we describe the anatomy and mucosal immune system of the female reproductive tract, and discuss bioengineering strategies to design mucosal vaccines that overcome delivery challenges and coordinate the presentation kinetics and compartmentalization of antigens and adjuvants to relevant mucosal immune cell subsets. In particular, we describe recent progress in understanding the role of specific mucosal dendritic cell subsets in facilitating immune responses to pathogenic microbes in the genital mucosa. We also discuss the development of pathogen‐mimicking materials that may be useful for engineering protective immunity in this mucosal niche. WIREs Nanomed Nanobiotechnol 2015, 8:107–122. doi: 10.1002/wnan.1359 For further resources related to this article, please visit the WIREs website.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>mucosal</json:string><json:string>nanoparticles</json:string><json:string>immune</json:string><json:string>epithelial</json:string><json:string>dendritic</json:string><json:string>vaccine</json:string><json:string>immunol</json:string><json:string>genital</json:string><json:string>receptor</json:string><json:string>adjuvant</json:string><json:string>epithelium</json:string><json:string>pathogen</json:string><json:string>reproductive</json:string><json:string>wiley periodical</json:string><json:string>node</json:string><json:string>lymphoid</json:string><json:string>nanoparticle</json:string><json:string>liposome</json:string><json:string>intravaginal</json:string><json:string>subset</json:string><json:string>macrophage</json:string><json:string>plga</json:string><json:string>lymph node</json:string><json:string>mucus</json:string><json:string>murine</json:string><json:string>submucosal</json:string><json:string>monocyte</json:string><json:string>vedcs</json:string><json:string>mucosal surface</json:string><json:string>immune response</json:string><json:string>nanomedicine</json:string><json:string>ccr6</json:string><json:string>mucosal niche</json:string><json:string>iwasaki</json:string><json:string>langerhans</json:string><json:string>transcytosis</json:string><json:string>squamous</json:string><json:string>stis</json:string><json:string>immunization</json:string><json:string>vaginal epithelium</json:string><json:string>reproductive tract</json:string><json:string>reprod</json:string><json:string>acidic</json:string><json:string>wang</json:string><json:string>mpps</json:string><json:string>plga nanoparticles</json:string><json:string>virion</json:string><json:string>pharm</json:string><json:string>lipid</json:string><json:string>lamina</json:string><json:string>chemokine</json:string><json:string>chemokines</json:string><json:string>mucin</json:string><json:string>effector</json:string><json:string>lymphocyte</json:string><json:string>herpes</json:string><json:string>precursor</json:string><json:string>viral</json:string><json:string>wire nanomedicine</json:string><json:string>nanobiotechnology</json:string><json:string>nanobiotechnology engineering immunity</json:string><json:string>antimicrobial</json:string><json:string>propria</json:string><json:string>leukocyte</json:string><json:string>reproductive tissue</json:string><json:string>icmvs</json:string><json:string>genital tract</json:string><json:string>female reproductive tract</json:string><json:string>dendritic cell</json:string><json:string>squamous epithelial cell</json:string><json:string>epithelial cell</json:string><json:string>professional cell</json:string><json:string>lymphoid tissue</json:string><json:string>mucin protein</json:string><json:string>lamina propria</json:string><json:string>mucosal immunity</json:string><json:string>antigen delivery</json:string><json:string>langerhans cell</json:string><json:string>polymer</json:string><json:string>vaginal</json:string><json:string>lymph</json:string><json:string>mucosal site</json:string><json:string>reprod immunol</json:string><json:string>vaginal mucosa</json:string><json:string>proc natl acad</json:string><json:string>vaginal tract</json:string><json:string>control release</json:string><json:string>lower genital tract</json:string><json:string>drug deliv</json:string><json:string>murine model</json:string><json:string>vaginal immunization</json:string><json:string>lymphoid structure</json:string><json:string>inflammation</json:string><json:string>inflammatory</json:string><json:string>peptide</json:string><json:string>neonatal</json:string><json:string>mucosal delivery</json:string><json:string>mucosal immune system</json:string><json:string>mucus penetration</json:string><json:string>vaginal epithelial</json:string><json:string>oral delivery</json:string><json:string>surface functionalized</json:string><json:string>vaginal epithelial dendritic cell</json:string><json:string>intravaginal delivery</json:string><json:string>mucosal tissue</json:string><json:string>mucosal adjuvant</json:string><json:string>recycling receptor</json:string><json:string>recent study</json:string><json:string>surface charge</json:string><json:string>submucosal dendritic cell</json:string><json:string>major focus</json:string><json:string>important role</json:string><json:string>mucosal immunol</json:string><json:string>subepithelial space</json:string><json:string>adaptive immunity</json:string><json:string>innate immunity</json:string><json:string>vaccine delivery</json:string><json:string>protective immunity</json:string><json:string>genital mucosa</json:string><json:string>immunity</json:string><json:string>vaccination</json:string><json:string>infection</json:string></teeft></keywords><author><json:item><name>Renuka Ramanathan</name><affiliations><json:string>Department of Bioengineering, University of Washington, WA, Seattle, USA</json:string></affiliations></json:item><json:item><name>Kim Woodrow</name><affiliations><json:string>Department of Bioengineering, University of Washington, WA, Seattle, USA</json:string><json:string>E-mail: woodrow@uw.edu</json:string></affiliations></json:item></author><articleId><json:string>WNAN1359</json:string></articleId><arkIstex>ark:/67375/WNG-QT8G269T-H</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>reviewArticle</json:string></originalGenre><abstract>The mucosal surfaces of the genital tract are the site of entry to over 30 different bacterial, parasitic, and viral pathogens that are the cause of sexually transmitted infections (STIs) including HIV. Women and adolescent girls are more severely impacted by STIs than men due in part to a greater biological susceptibility for acquiring infections and differences in disease sequelae. While it is widely accepted that preventative vaccines against the most commonly transmitted STIs would have a major impact on decreasing the global health burden of STIs for women worldwide, several challenges preclude their development. The female genital tract is a complex niche of microflora, hormonal influences, and immune tissues and cells that result in a mucosal immune system that is distinct from other mucosal sites and from our systemic immune system. An appreciation of these differences and their effect on shaping mucosal immunity to sexually transmitted pathogens is an important determinant for the design of effective STI vaccines. Here we describe the anatomy and mucosal immune system of the female reproductive tract, and discuss bioengineering strategies to design mucosal vaccines that overcome delivery challenges and coordinate the presentation kinetics and compartmentalization of antigens and adjuvants to relevant mucosal immune cell subsets. In particular, we describe recent progress in understanding the role of specific mucosal dendritic cell subsets in facilitating immune responses to pathogenic microbes in the genital mucosa. We also discuss the development of pathogen‐mimicking materials that may be useful for engineering protective immunity in this mucosal niche. WIREs Nanomed Nanobiotechnol 2015, 8:107–122. doi: 10.1002/wnan.1359 For further resources related to this article, please visit the WIREs website.</abstract><qualityIndicators><score>10</score><pdfWordCount>8984</pdfWordCount><pdfCharCount>61031</pdfCharCount><pdfVersion>1.4</pdfVersion><pdfPageCount>16</pdfPageCount><pdfPageSize>594 x 783 pts</pdfPageSize><pdfWordsPerPage>562</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>268</abstractWordCount><abstractCharCount>1840</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Engineering immunity in the mucosal niche against sexually transmitted infections</title><genre><json:string>review-article</json:string></genre><host><title>Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1002/(ISSN)1939-0041</json:string></doi><issn><json:string>1939-5116</json:string></issn><eissn><json:string>1939-0041</json:string></eissn><publisherId><json:string>WNAN</json:string></publisherId><volume>8</volume><issue>1</issue><pages><first>107</first><last>122</last><total>16</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Nanomedicine for Infectious Disease</value></json:item><json:item><value>Advanced Review</value></json:item><json:item><value>Advanced Reviews</value></json:item></subject></host><ark><json:string>ark:/67375/WNG-QT8G269T-H</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - nanoscience & nanotechnology</json:string><json:string>2 - medicine, research & experimental</json:string></wos><scienceMetrix><json:string>1 - applied sciences</json:string><json:string>2 - enabling & strategic technologies</json:string><json:string>3 - nanoscience & nanotechnology</json:string></scienceMetrix><scopus></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2016</publicationDate><copyrightDate>2016</copyrightDate><doi><json:string>10.1002/wnan.1359</json:string></doi><id>72A9720C0E2D5A684AC4D6A6A7B7A7FB8DC701DE</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-QT8G269T-H/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-QT8G269T-H/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-QT8G269T-H/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Engineering immunity in the mucosal niche against sexually transmitted infections</title><title level="a" type="short">Engineering immunity in the mucosal niche against sexually transmitted infections</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>Hoboken, USA</pubPlace><availability><licence>© 2015 Wiley Periodicals, Inc.</licence></availability><date type="published" when="2016-01"></date></publicationStmt><notesStmt><note type="content-type" subtype="review-article" source="reviewArticle" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Engineering immunity in the mucosal niche against sexually transmitted infections</title><title level="a" type="short">Engineering immunity in the mucosal niche against sexually transmitted infections</title><author xml:id="author-0000"><persName><forename type="first">Renuka</forename><surname>Ramanathan</surname></persName><affiliation><orgName type="institution">Department of Bioengineering, University of Washington</orgName><address><settlement>Seattle</settlement><region>WA</region><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0001" role="corresp"><persName><forename type="first">Kim</forename><surname>Woodrow</surname></persName><affiliation><orgName type="institution">Department of Bioengineering, University of Washington</orgName><address><settlement>Seattle</settlement><region>WA</region><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><idno type="istex">72A9720C0E2D5A684AC4D6A6A7B7A7FB8DC701DE</idno><idno type="ark">ark:/67375/WNG-QT8G269T-H</idno><idno type="DOI">10.1002/wnan.1359</idno><idno type="unit">WNAN1359</idno><idno type="toTypesetVersion">file:WNAN.WNAN1359.pdf</idno></analytic><monogr><title level="j" type="main">Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><title level="j" type="alt">WILEY INTERDISCIPLINARY REVIEWS: NANOMEDICINE AND NANOBIOTECHNOLOGY</title><idno type="pISSN">1939-5116</idno><idno type="eISSN">1939-0041</idno><idno type="book-DOI">10.1002/(ISSN)1939-0041</idno><idno type="book-part-DOI">10.1002/wnan.2016.8.issue-1</idno><idno type="product">WNAN</idno><imprint><biblScope unit="vol">8</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="107">107</biblScope><biblScope unit="page" to="122">122</biblScope><biblScope unit="page-count">16</biblScope><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>Hoboken, USA</pubPlace><date type="published" when="2016-01"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract style="main" xml:id="wnan1359-abs-0001"><p xml:id="wnan1359-para-0001">The mucosal surfaces of the genital tract are the site of entry to over 30 different bacterial, parasitic, and viral pathogens that are the cause of sexually transmitted infections (STIs) including HIV. Women and adolescent girls are more severely impacted by STIs than men due in part to a greater biological susceptibility for acquiring infections and differences in disease sequelae. While it is widely accepted that preventative vaccines against the most commonly transmitted STIs would have a major impact on decreasing the global health burden of STIs for women worldwide, several challenges preclude their development. The female genital tract is a complex niche of microflora, hormonal influences, and immune tissues and cells that result in a mucosal immune system that is distinct from other mucosal sites and from our systemic immune system. An appreciation of these differences and their effect on shaping mucosal immunity to sexually transmitted pathogens is an important determinant for the design of effective STI vaccines. Here we describe the anatomy and mucosal immune system of the female reproductive tract, and discuss bioengineering strategies to design mucosal vaccines that overcome delivery challenges and coordinate the presentation kinetics and compartmentalization of antigens and adjuvants to relevant mucosal immune cell subsets. In particular, we describe recent progress in understanding the role of specific mucosal dendritic cell subsets in facilitating immune responses to pathogenic microbes in the genital mucosa. We also discuss the development of pathogen‐mimicking materials that may be useful for engineering protective immunity in this mucosal niche. <hi rend="italic">WIREs Nanomed Nanobiotechnol</hi> 2015, 8:107–122. doi: 10.1002/wnan.1359</p><p>For further resources related to this article, please visit the <ref type="url">http://wires.wiley.com/remdoi.cgi?doi=10.1002/wnan.1359</ref>.</p></abstract><textClass><keywords rend="articleCategory"><term>Advanced Review</term></keywords><keywords rend="tocHeading1"><term>Advanced Reviews</term></keywords></textClass><textClass><keywords ana="subject"><term ref="http://psi.wiley.com/subject/19395116/2NID">Nanomedicine for Infectious Disease</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-QT8G269T-H/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en" xml:id="wnan1359"><header><publicationMeta level="product"><publisherInfo><publisherName>John Wiley & Sons, Inc.</publisherName><publisherLoc>Hoboken, USA</publisherLoc></publisherInfo><doi>10.1002/(ISSN)1939-0041</doi><issn type="print">1939-5116</issn><issn type="electronic">1939-0041</issn><idGroup><id type="product" value="WNAN"></id></idGroup><titleGroup><title type="main" sort="WILEY INTERDISCIPLINARY REVIEWS: NANOMEDICINE AND NANOBIOTECHNOLOGY">Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><title type="short">WIREs Nanomed Nanobiotechnol</title></titleGroup></publicationMeta><publicationMeta level="part" position="10"><doi origin="wiley">10.1002/wnan.2016.8.issue-1</doi><copyright ownership="publisher">© 2016 Wiley Periodicals, Inc.</copyright><numberingGroup><numbering type="journalVolume" number="8">8</numbering><numbering type="journalIssue">1</numbering></numberingGroup><coverDate startDate="2016-01">January/February 2016</coverDate></publicationMeta><publicationMeta level="unit" position="80" type="reviewArticle" status="forIssue"><doi>10.1002/wnan.1359</doi><idGroup><id type="unit" value="WNAN1359"></id></idGroup><countGroup><count type="pageTotal" number="16"></count></countGroup><titleGroup><title type="articleCategory">Advanced Review</title><title type="tocHeading1">Advanced Reviews</title></titleGroup><copyright ownership="publisher">© 2015 Wiley Periodicals, Inc.</copyright><eventGroup><event type="manuscriptReceived" date="2014-08-03"></event><event type="manuscriptRevised" date="2015-05-04"></event><event type="manuscriptAccepted" date="2015-06-03"></event><event type="xmlCreated" agent="Laserwords Private Ltd." date="2015-06-19"></event><event type="publishedOnlineEarlyUnpaginated" date="2015-07-07"></event><event type="publishedOnlineFinalForm" date="2015-12-25"></event><event type="firstOnline" date="2015-07-07"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:5.0.6 mode:FullText" date="2017-02-10"></event></eventGroup><numberingGroup><numbering type="pageFirst">107</numbering><numbering type="pageLast">122</numbering></numberingGroup><correspondenceTo>Correspondence to: <email>woodrow@uw.edu</email></correspondenceTo><subjectInfo><subject href="http://psi.wiley.com/subject/19395116/2NID">Nanomedicine for Infectious Disease</subject></subjectInfo><linkGroup><link type="toTypesetVersion" href="file:WNAN.WNAN1359.pdf"></link></linkGroup></publicationMeta><contentMeta><titleGroup><title type="main">Engineering immunity in the mucosal niche against sexually transmitted infections</title><title type="short">Engineering immunity in the mucosal niche against sexually transmitted infections</title></titleGroup><creators><creator creatorRole="author" xml:id="wnan1359-cr-0001" affiliationRef="#wnan1359-aff-0001"><personName><givenNames>Renuka</givenNames>
<familyName>Ramanathan</familyName></personName></creator><creator creatorRole="author" xml:id="wnan1359-cr-0002" affiliationRef="#wnan1359-aff-0001" corresponding="yes"><personName><givenNames>Kim</givenNames>
<familyName>Woodrow</familyName></personName></creator></creators><affiliationGroup xml:id="wnan1359-affgp-0001"><affiliation countryCode="US" xml:id="wnan1359-aff-0001"><orgName>Department of Bioengineering, University of Washington</orgName><address><city>Seattle</city><countryPart>WA</countryPart><country>USA</country></address></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:id="wnan1359-abs-0001"><p xml:id="wnan1359-para-0001">The mucosal surfaces of the genital tract are the site of entry to over 30 different bacterial, parasitic, and viral pathogens that are the cause of sexually transmitted infections (STIs) including HIV. Women and adolescent girls are more severely impacted by STIs than men due in part to a greater biological susceptibility for acquiring infections and differences in disease sequelae. While it is widely accepted that preventative vaccines against the most commonly transmitted STIs would have a major impact on decreasing the global health burden of STIs for women worldwide, several challenges preclude their development. The female genital tract is a complex niche of microflora, hormonal influences, and immune tissues and cells that result in a mucosal immune system that is distinct from other mucosal sites and from our systemic immune system. An appreciation of these differences and their effect on shaping mucosal immunity to sexually transmitted pathogens is an important determinant for the design of effective STI vaccines. Here we describe the anatomy and mucosal immune system of the female reproductive tract, and discuss bioengineering strategies to design mucosal vaccines that overcome delivery challenges and coordinate the presentation kinetics and compartmentalization of antigens and adjuvants to relevant mucosal immune cell subsets. In particular, we describe recent progress in understanding the role of specific mucosal dendritic cell subsets in facilitating immune responses to pathogenic microbes in the genital mucosa. We also discuss the development of pathogen‐mimicking materials that may be useful for engineering protective immunity in this mucosal niche. <i>WIREs Nanomed Nanobiotechnol</i> 2015, 8:107–122. doi: 10.1002/wnan.1359</p><p>For further resources related to this article, please visit the <url href="http://wires.wiley.com/remdoi.cgi?doi=10.1002/wnan.1359">WIREs website</url>.</p></abstract></abstractGroup></contentMeta><noteGroup xml:id="wnan1359-ntgp-0001"><note xml:id="wnan1359-note-0001" numbered="no">Conflict of interest: The authors have declared no conflicts of interest for this article.</note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Engineering immunity in the mucosal niche against sexually transmitted infections</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Engineering immunity in the mucosal niche against sexually transmitted infections</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Engineering immunity in the mucosal niche against sexually transmitted infections</title></titleInfo><name type="personal"><namePart type="given">Renuka</namePart><namePart type="family">Ramanathan</namePart><affiliation>Department of Bioengineering, University of Washington, WA, Seattle, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Kim</namePart><namePart type="family">Woodrow</namePart><affiliation>Department of Bioengineering, University of Washington, WA, Seattle, USA</affiliation><affiliation>E-mail: woodrow@uw.edu</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="reviewArticle" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre><originInfo><publisher>John Wiley & Sons, Inc.</publisher><place><placeTerm type="text">Hoboken, USA</placeTerm></place><dateIssued encoding="w3cdtf">2016-01</dateIssued><dateCreated encoding="w3cdtf">2015-06-19</dateCreated><dateCaptured encoding="w3cdtf">2014-08-03</dateCaptured><dateValid encoding="w3cdtf">2015-06-03</dateValid><copyrightDate encoding="w3cdtf">2016</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><abstract>The mucosal surfaces of the genital tract are the site of entry to over 30 different bacterial, parasitic, and viral pathogens that are the cause of sexually transmitted infections (STIs) including HIV. Women and adolescent girls are more severely impacted by STIs than men due in part to a greater biological susceptibility for acquiring infections and differences in disease sequelae. While it is widely accepted that preventative vaccines against the most commonly transmitted STIs would have a major impact on decreasing the global health burden of STIs for women worldwide, several challenges preclude their development. The female genital tract is a complex niche of microflora, hormonal influences, and immune tissues and cells that result in a mucosal immune system that is distinct from other mucosal sites and from our systemic immune system. An appreciation of these differences and their effect on shaping mucosal immunity to sexually transmitted pathogens is an important determinant for the design of effective STI vaccines. Here we describe the anatomy and mucosal immune system of the female reproductive tract, and discuss bioengineering strategies to design mucosal vaccines that overcome delivery challenges and coordinate the presentation kinetics and compartmentalization of antigens and adjuvants to relevant mucosal immune cell subsets. In particular, we describe recent progress in understanding the role of specific mucosal dendritic cell subsets in facilitating immune responses to pathogenic microbes in the genital mucosa. We also discuss the development of pathogen‐mimicking materials that may be useful for engineering protective immunity in this mucosal niche. WIREs Nanomed Nanobiotechnol 2015, 8:107–122. doi: 10.1002/wnan.1359 For further resources related to this article, please visit the WIREs website.</abstract><relatedItem type="host"><titleInfo><title>Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title></titleInfo><titleInfo type="abbreviated"><title>WIREs Nanomed Nanobiotechnol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>index-terms</genre><topic authorityURI="http://psi.wiley.com/subject/19395116/2NID">Nanomedicine for Infectious Disease</topic></subject><subject><genre>article-category</genre><topic>Advanced Review</topic><topic>Advanced Reviews</topic></subject><identifier type="ISSN">1939-5116</identifier><identifier type="eISSN">1939-0041</identifier><identifier type="DOI">10.1002/(ISSN)1939-0041</identifier><identifier type="PublisherID">WNAN</identifier><part><date>2016</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>107</start><end>122</end><total>16</total></extent></part></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0001"><titleInfo><title>Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women</title></titleInfo><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Kozlowski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Cu‐Uvin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Neutra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TP</namePart><namePart type="family">Flanigan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kozlowski PA, Cu‐Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 1997, 65:1387–1394.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>1387</start><end>1394</end></extent></part><relatedItem type="host"><titleInfo><title>Infect Immun</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>1387</start><end>1394</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0002"><titleInfo><title>Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus‐like particle vaccine in thermosensitive mucoadhesive delivery systems</title></titleInfo><name type="personal"><namePart type="given">J‐S</namePart><namePart type="family">Park</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y‐K</namePart><namePart type="family">Oh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M‐J</namePart><namePart type="family">Kang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C‐K</namePart><namePart type="family">Kim</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Park J‐S, Oh Y‐K, Kang M‐J, Kim C‐K. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus‐like particle vaccine in thermosensitive mucoadhesive delivery systems. J Med Virol 2003, 70:633–641.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>633</start><end>641</end></extent></part><relatedItem type="host"><titleInfo><title>J Med Virol</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>633</start><end>641</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0003"><titleInfo><title>Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle</title></titleInfo><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Kozlowski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SB</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RM</namePart><namePart type="family">Lynch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TP</namePart><namePart type="family">Flanigan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RR</namePart><namePart type="family">Patterson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Cu‐Uvin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Neutra</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu‐Uvin S, Neutra MR. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol 2002, 169:566–574.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>169</number></detail><extent unit="pages"><start>566</start><end>574</end></extent></part><relatedItem type="host"><titleInfo><title>J Immunol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>169</number></detail><extent unit="pages"><start>566</start><end>574</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0004"><titleInfo><title>World Health Organization. Global strategy for the prevention and control of sexually transmitted infections: 2006–2015: breaking the chain of transmission. Geneva, Switzerland: World Health Organization; 2007.</title></titleInfo><name type="corporate"><namePart>World Health Organization</namePart></name><genre>other</genre><part><date>2007</date></part></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0005"><titleInfo><title>Mucosal vaccination strategies for women</title></titleInfo><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Kozlowski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Cu‐Uvin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Neutra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TP</namePart><namePart type="family">Flanigan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kozlowski PA, Cu‐Uvin S, Neutra MR, Flanigan TP. Mucosal vaccination strategies for women. J Infect Dis 1999, 179(Suppl 3):S493–S498.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>179</number></detail><detail type="issue"><caption>no.</caption><number>Suppl 3</number></detail><extent unit="pages"><start>S493</start><end>S498</end></extent></part><relatedItem type="host"><titleInfo><title>J Infect Dis</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>179</number></detail><detail type="issue"><caption>no.</caption><number>Suppl 3</number></detail><extent unit="pages"><start>S493</start><end>S498</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0006"><titleInfo><title>WHO global strategy for the prevention and control of sexually transmitted infections: time for action</title></titleInfo><name type="personal"><namePart type="given">DA</namePart><namePart type="family">Lewis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Latif</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Ndowa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lewis DA, Latif AS, Ndowa F. WHO global strategy for the prevention and control of sexually transmitted infections: time for action. Sex Transm Infect 2007, 83:508–509.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>508</start><end>509</end></extent></part><relatedItem type="host"><titleInfo><title>Sex Transm Infect</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>508</start><end>509</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0007"><titleInfo><title>Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Weinstock</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Berman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Cates</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36:6–10.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>6</start><end>10</end></extent></part><relatedItem type="host"><titleInfo><title>Perspect Sex Reprod Health</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>6</start><end>10</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0008"><titleInfo><title>The estimated direct medical cost of sexually transmitted diseases among American youth, 2000</title></titleInfo><name type="personal"><namePart type="given">HW</namePart><namePart type="family">Chesson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Blandford</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TL</namePart><namePart type="family">Gift</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Tao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KL</namePart><namePart type="family">Irwin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health 2004, 36:11–19.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>11</start><end>19</end></extent></part><relatedItem type="host"><titleInfo><title>Perspect Sex Reprod Health</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>11</start><end>19</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0009"><titleInfo><title>HIV/AIDS in women: an expanding epidemic</title></titleInfo><name type="personal"><namePart type="given">TC</namePart><namePart type="family">Quinn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Overbaugh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 2005, 308:1582–1583.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>308</number></detail><extent unit="pages"><start>1582</start><end>1583</end></extent></part><relatedItem type="host"><titleInfo><title>Science</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>308</number></detail><extent unit="pages"><start>1582</start><end>1583</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0010"><titleInfo><title>Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. Immunobiology. 5th ed. New York: Garland Science; 2001.</title></titleInfo><note type="citation/reference">Janeway CA Jr, Travers P, Walport M, Shlomchik MJ. Immunobiology. 5th ed. New York: Garland Science; 2001.</note><name type="personal"><namePart type="given">CA</namePart><namePart type="family">Janeway Jr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Travers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Walport</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Shlomchik</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Garland Science</publisher><place><placeTerm type="text">New York</placeTerm></place></originInfo><part><date>2001</date></part></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0011"><titleInfo><title>Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections</title></titleInfo><name type="personal"><namePart type="given">DK</namePart><namePart type="family">Hickey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MV</namePart><namePart type="family">Patel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JV</namePart><namePart type="family">Fahey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CR</namePart><namePart type="family">Wira</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hickey DK, Patel MV, Fahey JV, Wira CR. Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 2011, 88:185–194.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>185</start><end>194</end></extent></part><relatedItem type="host"><titleInfo><title>J Reprod Immunol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>88</number></detail><extent unit="pages"><start>185</start><end>194</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0012"><titleInfo><title>Setting the stage: host invasion by HIV</title></titleInfo><name type="personal"><namePart type="given">F</namePart><namePart type="family">Hladik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">McElrath</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol 2008, 8:447–457.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>447</start><end>457</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Rev Immunol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>447</start><end>457</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0013"><titleInfo><title>Antiviral immune responses in the genital tract: clues for vaccines</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iwasaki A. Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol 2010, 10:699–711.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>699</start><end>711</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Rev Immunol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>699</start><end>711</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0014"><titleInfo><title>Female genital tract immunity: distinct immunological challenges for vaccine development</title></titleInfo><name type="personal"><namePart type="given">RK</namePart><namePart type="family">Naz</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Naz RK. Female genital tract immunity: distinct immunological challenges for vaccine development. J Reprod Immunol 2011, 93:1–8. doi:10.1016/j.jri.2011.09.005.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>1</start><end>8</end></extent></part><relatedItem type="host"><titleInfo><title>J Reprod Immunol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>1</start><end>8</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0015"><titleInfo><title>Innate immunity in the female reproductive tract: role of sex hormones in regulating uterine epithelial cell protection against pathogens</title></titleInfo><name type="personal"><namePart type="given">DO</namePart><namePart type="family">Ochiel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JV</namePart><namePart type="family">Fahey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ghosh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SN</namePart><namePart type="family">Haddad</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CR</namePart><namePart type="family">Wira</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ochiel DO, Fahey JV, Ghosh M, Haddad SN, Wira CR. Innate immunity in the female reproductive tract: role of sex hormones in regulating uterine epithelial cell protection against pathogens. Curr Womens Health Rev 2008, 4:102–117.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>102</start><end>117</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Womens Health Rev</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>102</start><end>117</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0016"><titleInfo><title>Reinforcement of epithelial cell adhesion to basement membrane by a bacterial pathogen as a new infectious stratagem</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Kim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ogawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Mimuro</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Sasakawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kim M, Ogawa M, Mimuro H, Sasakawa C. Reinforcement of epithelial cell adhesion to basement membrane by a bacterial pathogen as a new infectious stratagem. Virulence 2010, 1:52–55.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>52</start><end>55</end></extent></part><relatedItem type="host"><titleInfo><title>Virulence</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>52</start><end>55</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0017"><titleInfo><title>Transitional changes in the surface epithelium of the cycling mouse vagina, cervix and uterus: scanning electron microscopic studies</title></titleInfo><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Lamb</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RR</namePart><namePart type="family">Newbold</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WE</namePart><namePart type="family">Stumpf</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">McLachlan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lamb JC, Newbold RR, Stumpf WE, McLachlan JA. Transitional changes in the surface epithelium of the cycling mouse vagina, cervix and uterus: scanning electron microscopic studies. Biol Reprod 1978, 19:701–711.</note><part><date>1978</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>701</start><end>711</end></extent></part><relatedItem type="host"><titleInfo><title>Biol Reprod</title></titleInfo><part><date>1978</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>701</start><end>711</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0018"><titleInfo><title>Cell‐free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells</title></titleInfo><name type="personal"><namePart type="given">MD</namePart><namePart type="family">Bobardt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">U</namePart><namePart type="family">Chatterji</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Selvarajah</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Van der Schueren</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">David</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Kahn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Gallay</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bobardt MD, Chatterji U, Selvarajah S, Van der Schueren B, David G, Kahn B, Gallay PA. Cell‐free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol 2006, 81:395–405.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>395</start><end>405</end></extent></part><relatedItem type="host"><titleInfo><title>J Virol</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>395</start><end>405</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0019"><titleInfo><title>Initial events in establishing vaginal entry and infection by human immunodeficiency virus type‐1</title></titleInfo><name type="personal"><namePart type="given">FSP</namePart><namePart type="family">Hladik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Ballweber</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Lentz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Fialkow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Eschenbach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">McElrath</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hladik FSP, Ballweber L, Lentz G, Fialkow M, Eschenbach D, McElrath MJ. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type‐1. Immunity 2007, 26:257–270.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>257</start><end>270</end></extent></part><relatedItem type="host"><titleInfo><title>Immunity</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>257</start><end>270</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0020"><titleInfo><title>Dendritic cells and macrophages in the genitourinary tract</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Iijima</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Thompson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iijima N, Thompson JM, Iwasaki A. Dendritic cells and macrophages in the genitourinary tract. Mucosal Immunol 2008, 1:451–459.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>451</start><end>459</end></extent></part><relatedItem type="host"><titleInfo><title>Mucosal Immunol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>451</start><end>459</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0021"><titleInfo><title>Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Wira</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KG</namePart><namePart type="family">Tschudy</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wira C, Tschudy KG. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am J Reprod Immunol 2005, 53:65–76.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>53</number></detail><extent unit="pages"><start>65</start><end>76</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Reprod Immunol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>53</number></detail><extent unit="pages"><start>65</start><end>76</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0022"><titleInfo><title>Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Shaykhiev</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Bals</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shaykhiev R, Bals R. Interactions between epithelial cells and leukocytes in immunity and tissue homeostasis. J Leukoc Biol 2007, 82:1–15.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>82</number></detail><extent unit="pages"><start>1</start><end>15</end></extent></part><relatedItem type="host"><titleInfo><title>J Leukoc Biol</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>82</number></detail><extent unit="pages"><start>1</start><end>15</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0023"><titleInfo><title>Mucosal dendritic cells</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iwasaki A. Mucosal dendritic cells. Annu Rev Immunol 2007, 25:381–418.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>381</start><end>418</end></extent></part><relatedItem type="host"><titleInfo><title>Annu Rev Immunol</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>381</start><end>418</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0024"><titleInfo><title>Vaginal epithelial dendritic cells renew from bone marrow precursors</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Iijima</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MM</namePart><namePart type="family">Linehan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Saeland</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iijima N, Linehan MM, Saeland S, Iwasaki A. Vaginal epithelial dendritic cells renew from bone marrow precursors. Proc Natl Acad Sci USA 2007, 104:19061–19066.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>19061</start><end>19066</end></extent></part><relatedItem type="host"><titleInfo><title>Proc Natl Acad Sci USA</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>104</number></detail><extent unit="pages"><start>19061</start><end>19066</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0025"><titleInfo><title>Origin, homeostasis and function of Langerhans cells and other langerin‐expressing dendritic cells</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Merad</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Ginhoux</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Collin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin‐expressing dendritic cells. Nat Rev Immunol 2008, 8:935–947.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>935</start><end>947</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Rev Immunol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>935</start><end>947</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0026"><titleInfo><title>Vaginal submucosal dendritic cells, but not langerhans cells, induce protective th1 responses to herpes simplex virus‐2</title></titleInfo><name type="personal"><namePart type="given">XDE</namePart><namePart type="family">Zhao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Soderberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Linehan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Spezzano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Zhu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Knipe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zhao XDE, Soderberg K, Linehan M, Spezzano D, Zhu J, Knipe DM, Iwasaki A. Vaginal submucosal dendritic cells, but not langerhans cells, induce protective th1 responses to herpes simplex virus‐2. J Exp Med 2003, 197:153–162.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>197</number></detail><extent unit="pages"><start>153</start><end>162</end></extent></part><relatedItem type="host"><titleInfo><title>J Exp Med</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>197</number></detail><extent unit="pages"><start>153</start><end>162</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0027"><titleInfo><title>Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Iijima</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Mattei</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iijima N, Mattei LM, Iwasaki A. Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc Natl Acad Sci USA 2011, 108:284–289.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>284</start><end>289</end></extent></part><relatedItem type="host"><titleInfo><title>Proc Natl Acad Sci USA</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>284</start><end>289</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0028"><titleInfo><title>Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo</title></titleInfo><name type="personal"><namePart type="given">MEN</namePart><namePart type="family">Le Borgne</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Goubier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Lira</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JC</namePart><namePart type="family">Sirard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">van Rooijen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Caux</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Aït‐Yahia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Vicari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Kaiserlian</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Le Borgne MEN, Goubier A, Lira SA, Sirard JC, van Rooijen N, Caux C, Aït‐Yahia S, Vicari A, Kaiserlian D, et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 2006, 24:191–201.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>191</start><end>201</end></extent></part><relatedItem type="host"><titleInfo><title>Immunity</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>191</start><end>201</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0029"><titleInfo><title>Mucosal immunity: some historical perspective on host‐pathogen interactions and implications for mucosal vaccines</title></titleInfo><name type="personal"><namePart type="given">PL</namePart><namePart type="family">Ogra</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ogra PL. Mucosal immunity: some historical perspective on host‐pathogen interactions and implications for mucosal vaccines. Immunol Cell Biol 2003, 81:23–33.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>23</start><end>33</end></extent></part><relatedItem type="host"><titleInfo><title>Immunol Cell Biol</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>23</start><end>33</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0030"><titleInfo><title>Collaboration of epithelial cells with organized mucosal lymphoid tissues</title></titleInfo><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Neutra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NJ</namePart><namePart type="family">Mantis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J‐P</namePart><namePart type="family">Kraehenbuhl</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Neutra MR, Mantis NJ, Kraehenbuhl J‐P. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001, 2:1004–1009.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>1004</start><end>1009</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Immunol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>1004</start><end>1009</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0031"><titleInfo><title>Mucin genes expressed by human female reproductive tract epithelia</title></titleInfo><name type="personal"><namePart type="given">IK</namePart><namePart type="family">Gipson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SB</namePart><namePart type="family">Ho</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SJ</namePart><namePart type="family">Spurr‐Michaud</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Tisdale</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Q</namePart><namePart type="family">Zhan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Torlakovic</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Pudney</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">Anderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">NW</namePart><namePart type="family">Toribara</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Hill</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gipson IK, Ho SB, Spurr‐Michaud SJ, Tisdale AS, Zhan Q, Torlakovic E, Pudney J, Anderson DJ, Toribara NW, Hill JA. Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod 1997, 56:999–1011.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>999</start><end>1011</end></extent></part><relatedItem type="host"><titleInfo><title>Biol Reprod</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>999</start><end>1011</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0032"><titleInfo><title>Diffusion of macromolecules and virus‐like particles in human cervical mucus</title></titleInfo><name type="personal"><namePart type="given">SS</namePart><namePart type="family">Olmsted</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JL</namePart><namePart type="family">Padgett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AI</namePart><namePart type="family">Yudin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KJ</namePart><namePart type="family">Whaley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TR</namePart><namePart type="family">Moench</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Cone</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus‐like particles in human cervical mucus. Biophys J 2001, 81:1930–1937.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>1930</start><end>1937</end></extent></part><relatedItem type="host"><titleInfo><title>Biophys J</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>1930</start><end>1937</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0033"><titleInfo><title>Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections</title></titleInfo><name type="personal"><namePart type="given">CR</namePart><namePart type="family">Wira</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MV</namePart><namePart type="family">Patel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Ghosh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Mukura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JV</namePart><namePart type="family">Fahey</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wira CR, Patel MV, Ghosh M, Mukura L, Fahey JV. Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol 2011, 65:196–211.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>196</start><end>211</end></extent></part><relatedItem type="host"><titleInfo><title>Am J Reprod Immunol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>65</number></detail><extent unit="pages"><start>196</start><end>211</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0034"><titleInfo><title>Transfer of IgG in the female genital tract by MHC class I‐related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection</title></titleInfo><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Palaniyandi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Zeng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Tuo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DC</namePart><namePart type="family">Roopenian</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Zhu</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Li Z, Palaniyandi S, Zeng R, Tuo W, Roopenian DC, Zhu X. Transfer of IgG in the female genital tract by MHC class I‐related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection. Proc Natl Acad Sci USA 2011, 108:4388–4393.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>4388</start><end>4393</end></extent></part><relatedItem type="host"><titleInfo><title>Proc Natl Acad Sci USA</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>108</number></detail><extent unit="pages"><start>4388</start><end>4393</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0035"><titleInfo><title>Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus</title></titleInfo><name type="personal"><namePart type="given">SKHK</namePart><namePart type="family">Lai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Shukair</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">YY</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Figueiredo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Cone</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TJ</namePart><namePart type="family">Hope</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Hanes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lai SKHK, Shukair S, Wang YY, Figueiredo A, Cone R, Hope TJ, Hanes J. Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 2009, 83:11196–11200.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>11196</start><end>11200</end></extent></part><relatedItem type="host"><titleInfo><title>J Virol</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>11196</start><end>11200</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0036"><titleInfo><title>Vaginal pH neutralization by semen as a cofactor of HIV transmission</title></titleInfo><name type="personal"><namePart type="given">J‐P</namePart><namePart type="family">Bouvet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Grésenguet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">Bélec</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bouvet J‐P, Grésenguet G, Bélec L. Vaginal pH neutralization by semen as a cofactor of HIV transmission. Clin Microbiol Infect 1997, 3:19–23.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>19</start><end>23</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Microbiol Infect</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>19</start><end>23</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0037"><titleInfo><title>Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Brabin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Roberts</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Fairbrother</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Mandal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SP</namePart><namePart type="family">Higgins</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Chandiok</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Wood</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Barnard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HC</namePart><namePart type="family">Kitchener</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Brabin L, Roberts SA, Fairbrother E, Mandal D, Higgins SP, Chandiok S, Wood P, Barnard G, Kitchener HC. Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics. Sex Transm Infect 2005, 81:483–487.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>483</start><end>487</end></extent></part><relatedItem type="host"><titleInfo><title>Sex Transm Infect</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><extent unit="pages"><start>483</start><end>487</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0038"><titleInfo><title>Endocervical pH measured in vivo through the normal menstrual cycle</title></titleInfo><name type="personal"><namePart type="given">RR</namePart><namePart type="family">Macdonald</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">IB</namePart><namePart type="family">Lumley</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Macdonald RR, Lumley IB. Endocervical pH measured in vivo through the normal menstrual cycle. Obstet Gynecol 1970, 35:202–206.</note><part><date>1970</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>202</start><end>206</end></extent></part><relatedItem type="host"><titleInfo><title>Obstet Gynecol</title></titleInfo><part><date>1970</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>202</start><end>206</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0039"><titleInfo><title>Human cervicovaginal mucus contains an activity that hinders HIV‐1 movement</title></titleInfo><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Shukair SA Allen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GC</namePart><namePart type="family">Cianci</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">Stieh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Anderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Baig</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CJ</namePart><namePart type="family">Gioia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EJ</namePart><namePart type="family">Spongberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SM</namePart><namePart type="family">Kauffman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MD</namePart><namePart type="family">McRaven</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shukair SA Allen SA, Cianci GC, Stieh DJ, Anderson MR, Baig SM, Gioia CJ, Spongberg EJ, Kauffman SM, McRaven MD, et al. Human cervicovaginal mucus contains an activity that hinders HIV‐1 movement. Mucosal Immunol 2013, 6:427–434.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>427</start><end>434</end></extent></part><relatedItem type="host"><titleInfo><title>Mucosal Immunol</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>427</start><end>434</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0040"><titleInfo><title>IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections</title></titleInfo><name type="personal"><namePart type="given">YY</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Kannan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KL</namePart><namePart type="family">Nunn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Murphy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DB</namePart><namePart type="family">Subramani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Moench</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Cone</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SK</namePart><namePart type="family">Lai</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wang YY, Kannan A, Nunn KL, Murphy MA, Subramani DB, Moench T, Cone R, Lai SK. IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections. Mucosal Immunol 2014, 7:1036–1044.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>1036</start><end>1044</end></extent></part><relatedItem type="host"><titleInfo><title>Mucosal Immunol</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>1036</start><end>1044</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0041"><titleInfo><title>Leukocytes migrate through three‐dimensional gels of midcycle cervical mucus</title></titleInfo><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Parkhurst</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WM</namePart><namePart type="family">Saltzman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Parkhurst MR, Saltzman WM. Leukocytes migrate through three‐dimensional gels of midcycle cervical mucus. Cell Immunol 1994, 156:77–94.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>156</number></detail><extent unit="pages"><start>77</start><end>94</end></extent></part><relatedItem type="host"><titleInfo><title>Cell Immunol</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>156</number></detail><extent unit="pages"><start>77</start><end>94</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0042"><titleInfo><title>Mucosal immunoglobulins</title></titleInfo><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Woof</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Mestecky</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol Rev 2005, 206:64–82.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>206</number></detail><extent unit="pages"><start>64</start><end>82</end></extent></part><relatedItem type="host"><titleInfo><title>Immunol Rev</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>206</number></detail><extent unit="pages"><start>64</start><end>82</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0043"><titleInfo><title>Unique features of antiviral immune system of the vaginal mucosa</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Kumamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kumamoto Y, Iwasaki A. Unique features of antiviral immune system of the vaginal mucosa. Curr Opin Immunol 2012, 24:411–416.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>411</start><end>416</end></extent></part><relatedItem type="host"><titleInfo><title>Curr Opin Immunol</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>24</number></detail><extent unit="pages"><start>411</start><end>416</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0044"><titleInfo><title>Mucosal dendritic cells in immunity and inflammation</title></titleInfo><name type="personal"><namePart type="given">BL</namePart><namePart type="family">Kelsall</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Rescigno</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kelsall BL, Rescigno M. Mucosal dendritic cells in immunity and inflammation. Nat Immunol 2004, 5:1091–1095.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>1091</start><end>1095</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Immunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>1091</start><end>1095</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0045"><titleInfo><title>A vaccine strategy that protects against genital herpes by establishing local memory T cells</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Shin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Shin H, Iwasaki A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 2012, 491:463–467.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>491</number></detail><extent unit="pages"><start>463</start><end>467</end></extent></part><relatedItem type="host"><titleInfo><title>Nature</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>491</number></detail><extent unit="pages"><start>463</start><end>467</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0046"><titleInfo><title>Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4</title></titleInfo><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Mikhak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JP</namePart><namePart type="family">Strassner</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AD</namePart><namePart type="family">Luster</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mikhak Z, Strassner JP, Luster AD. Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4. J Exp Med 2013, 210:1855–1869.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>210</number></detail><extent unit="pages"><start>1855</start><end>1869</end></extent></part><relatedItem type="host"><titleInfo><title>J Exp Med</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>210</number></detail><extent unit="pages"><start>1855</start><end>1869</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0047"><titleInfo><title>Selective imprinting of gut‐homing T cells by Peyer's patch dendritic cells</title></titleInfo><name type="personal"><namePart type="given">JR</namePart><namePart type="family">Mora</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Bono</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Manjunath</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Weninger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LL</namePart><namePart type="family">Cavanagh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Rosemblatt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">UH</namePart><namePart type="family">Von Andrian</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, Von Andrian UH. Selective imprinting of gut‐homing T cells by Peyer's patch dendritic cells. Nature 2003, 424:88–93.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>424</number></detail><extent unit="pages"><start>88</start><end>93</end></extent></part><relatedItem type="host"><titleInfo><title>Nature</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>424</number></detail><extent unit="pages"><start>88</start><end>93</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0048"><titleInfo><title>The CC chemokine CCL20 and its receptor CCR6</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Schutyser</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Struyf</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Van Damme</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003, 14:409–426.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>409</start><end>426</end></extent></part><relatedItem type="host"><titleInfo><title>Cytokine Growth Factor Rev</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>409</start><end>426</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0049"><titleInfo><title>Chemokines: immunology's high impact factors</title></titleInfo><name type="personal"><namePart type="given">CR</namePart><namePart type="family">Mackay</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mackay CR. Chemokines: immunology's high impact factors. Nat Immunol 2001, 2:95–101.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>95</start><end>101</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Immunol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>95</start><end>101</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0050"><titleInfo><title>CCR6 as a possible therapeutic target in psoriasis</title></titleInfo><name type="personal"><namePart type="given">MN</namePart><namePart type="family">Hedrick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Lonsdorf</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ST</namePart><namePart type="family">Hwang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Farber</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hedrick MN, Lonsdorf AS, Hwang ST, Farber JM. CCR6 as a possible therapeutic target in psoriasis. Expert Opin Ther Targets 2010, 14:911–922.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>911</start><end>922</end></extent></part><relatedItem type="host"><titleInfo><title>Expert Opin Ther Targets</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>14</number></detail><extent unit="pages"><start>911</start><end>922</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0051"><titleInfo><title>Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors</title></titleInfo><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Dieu‐Nosjean</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Massacrier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Homey</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Vanbervliet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Pin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Vicari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Lebecque</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Dezutter‐Dambuyant</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Schmitt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Zlotnik</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dieu‐Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, Lebecque S, Dezutter‐Dambuyant C, Schmitt D, Zlotnik A, et al. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 2000, 192:705–718.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>192</number></detail><extent unit="pages"><start>705</start><end>718</end></extent></part><relatedItem type="host"><titleInfo><title>J Exp Med</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>192</number></detail><extent unit="pages"><start>705</start><end>718</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0052"><titleInfo><title>CCR6 as a mediator of immunity in the lung and gut</title></titleInfo><name type="personal"><namePart type="given">T</namePart><namePart type="family">Ito</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WF</namePart><namePart type="family">Carson IV</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KA</namePart><namePart type="family">Cavassani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Connett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SL</namePart><namePart type="family">Kunkel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ito T, Carson WF IV, Cavassani KA, Connett JM, Kunkel SL. CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res 2011, 317:613–619.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>317</number></detail><extent unit="pages"><start>613</start><end>619</end></extent></part><relatedItem type="host"><titleInfo><title>Exp Cell Res</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>317</number></detail><extent unit="pages"><start>613</start><end>619</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0053"><titleInfo><title>Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)‐3alpha, MIP‐3beta, and secondary lymphoid organ chemokine</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Iwasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BL</namePart><namePart type="family">Kelsall</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Iwasaki A, Kelsall BL. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)‐3alpha, MIP‐3beta, and secondary lymphoid organ chemokine. J Exp Med 2000, 191:1381–1394.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>191</number></detail><extent unit="pages"><start>1381</start><end>1394</end></extent></part><relatedItem type="host"><titleInfo><title>J Exp Med</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>191</number></detail><extent unit="pages"><start>1381</start><end>1394</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0054"><titleInfo><title>Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines</title></titleInfo><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Dieu‐Nosjean</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Vicari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Lebecque</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Caux</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dieu‐Nosjean MC, Vicari A, Lebecque S, Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J Leukoc Biol 1999, 66:252–262.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>252</start><end>262</end></extent></part><relatedItem type="host"><titleInfo><title>J Leukoc Biol</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>66</number></detail><extent unit="pages"><start>252</start><end>262</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0055"><titleInfo><title>Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Dieu MC Vanbervliet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Vicari</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Bridon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Oldham</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Aït‐Yahia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Brière</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Zlotnik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Lebecque</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Caux</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dieu MC Vanbervliet B, Vicari A, Bridon JM, Oldham E, Aït‐Yahia S, Brière F, Zlotnik A, Lebecque S, Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998, 188:373–386.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>188</number></detail><extent unit="pages"><start>373</start><end>386</end></extent></part><relatedItem type="host"><titleInfo><title>J Exp Med</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>188</number></detail><extent unit="pages"><start>373</start><end>386</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0056"><titleInfo><title>Directed cell migration via chemoattractants released from degradable microspheres</title></titleInfo><name type="personal"><namePart type="given">X</namePart><namePart type="family">Zhao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Jain</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HB</namePart><namePart type="family">Larman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Gonzalez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DJ</namePart><namePart type="family">Irvine</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zhao X, Jain S, Larman HB, Gonzalez S, Irvine DJ. Directed cell migration via chemoattractants released from degradable microspheres. Biomaterials 2005, 26:5048–5063.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>5048</start><end>5063</end></extent></part><relatedItem type="host"><titleInfo><title>Biomaterials</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>5048</start><end>5063</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0057"><titleInfo><title>Effects of MIP‐1α, MIP‐3α, and MIP‐3β on the induction of HIV gag‐specific immune response with DNA vaccines</title></titleInfo><name type="personal"><namePart type="given">R</namePart><namePart type="family">Song</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Liu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KW</namePart><namePart type="family">Leong</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Song R, Liu S, Leong KW. Effects of MIP‐1α, MIP‐3α, and MIP‐3β on the induction of HIV gag‐specific immune response with DNA vaccines. Mol Ther 2007, 15:1007–1015.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1007</start><end>1015</end></extent></part><relatedItem type="host"><titleInfo><title>Mol Ther</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>1007</start><end>1015</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0058"><titleInfo><title>Roles of antimicrobial peptides such as defensins in innate and adaptive immunity</title></titleInfo><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Oppenheim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Biragyn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LW</namePart><namePart type="family">Kwak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Yang</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Oppenheim JJ, Biragyn A, Kwak LW, Yang D. Roles of antimicrobial peptides such as defensins in innate and adaptive immunity. Ann Rheum Dis 2003, 62(Suppl 2):ii17–ii21.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><detail type="issue"><caption>no.</caption><number>Suppl 2</number></detail><extent unit="pages"><start>ii17</start><end>ii21</end></extent></part><relatedItem type="host"><titleInfo><title>Ann Rheum Dis</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><detail type="issue"><caption>no.</caption><number>Suppl 2</number></detail><extent unit="pages"><start>ii17</start><end>ii21</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0059"><titleInfo><title>Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Dürr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Peschel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dürr M, Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 2002, 70:6515–6517.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>6515</start><end>6517</end></extent></part><relatedItem type="host"><titleInfo><title>Infect Immun</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>70</number></detail><extent unit="pages"><start>6515</start><end>6517</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0060"><titleInfo><title>NP‐1, a rabbit alpha‐defensin, prevents the entry and intercellular spread of herpes simplex virus type 2</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Sinha</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Cheshenko</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RI</namePart><namePart type="family">Lehrer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BC</namePart><namePart type="family">Herold</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sinha S, Cheshenko N, Lehrer RI, Herold BC. NP‐1, a rabbit alpha‐defensin, prevents the entry and intercellular spread of herpes simplex virus type 2. Antimicrob Agents Chemother 2003, 47:494–500.</note><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>494</start><end>500</end></extent></part><relatedItem type="host"><titleInfo><title>Antimicrob Agents Chemother</title></titleInfo><part><date>2003</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>494</start><end>500</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0061"><titleInfo><title>Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Biragyn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Surenhu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Yang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PA</namePart><namePart type="family">Ruffini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BA</namePart><namePart type="family">Haines</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Klyushnenkova</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Oppenheim</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LW</namePart><namePart type="family">Kwak</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Biragyn A, Surenhu M, Yang D, Ruffini PA, Haines BA, Klyushnenkova E, Oppenheim JJ, Kwak LW. Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. J Immunol 2001, 167:6644–6653.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>167</number></detail><extent unit="pages"><start>6644</start><end>6653</end></extent></part><relatedItem type="host"><titleInfo><title>J Immunol</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>167</number></detail><extent unit="pages"><start>6644</start><end>6653</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0062"><titleInfo><title>Beta‐defensins: linking innate and adaptive immunity through dendritic and T cell CCR6</title></titleInfo><name type="personal"><namePart type="given">DCO</namePart><namePart type="family">Yang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SN</namePart><namePart type="family">Bykovskaia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Q</namePart><namePart type="family">Chen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Buffo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Shogan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Anderson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Schröder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">OM</namePart><namePart type="family">Howard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Oppenheim</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yang DCO, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM, Oppenheim JJ. Beta‐defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999, 286:525–528.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>525</start><end>528</end></extent></part><relatedItem type="host"><titleInfo><title>Science</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>286</number></detail><extent unit="pages"><start>525</start><end>528</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0063"><titleInfo><title>Antiinfective applications of toll‐like receptor 9 agonists</title></titleInfo><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Krieg</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Krieg AM. Antiinfective applications of toll‐like receptor 9 agonists. Proc Am Thorac Soc 2007, 4:289–294.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>289</start><end>294</end></extent></part><relatedItem type="host"><titleInfo><title>Proc Am Thorac Soc</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>289</start><end>294</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0064"><titleInfo><title>Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Vollmer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Krieg</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vollmer J, Krieg AM. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv Drug Deliv Rev 2009, 61:195–204.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>61</number></detail><extent unit="pages"><start>195</start><end>204</end></extent></part><relatedItem type="host"><titleInfo><title>Adv Drug Deliv Rev</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>61</number></detail><extent unit="pages"><start>195</start><end>204</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0065"><titleInfo><title>CpG DNA as mucosal adjuvant</title></titleInfo><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">McCluskie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HL</namePart><namePart type="family">Davis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">McCluskie MJ, Davis HL. CpG DNA as mucosal adjuvant. Vaccine 1999, 18:231–237.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>231</start><end>237</end></extent></part><relatedItem type="host"><titleInfo><title>Vaccine</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>18</number></detail><extent unit="pages"><start>231</start><end>237</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0066"><titleInfo><title>CpG DNA as a vaccine adjuvant</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Bode</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Zhao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Steinhagen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Kinjo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DM</namePart><namePart type="family">Klinman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM. CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 2011, 10:499–511.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>499</start><end>511</end></extent></part><relatedItem type="host"><titleInfo><title>Expert Rev Vaccines</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>499</start><end>511</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0067"><titleInfo><title>CD8+ T‐cell‐mediated cross‐clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides</title></titleInfo><name type="personal"><namePart type="given">JQ</namePart><namePart type="family">Jiang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Patrick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RB</namePart><namePart type="family">Moss</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KL</namePart><namePart type="family">Rosenthal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jiang JQ, Patrick A, Moss RB, Rosenthal KL. CD8+ T‐cell‐mediated cross‐clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides. J Virol 2005, 79:393–400.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>393</start><end>400</end></extent></part><relatedItem type="host"><titleInfo><title>J Virol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>393</start><end>400</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0068"><titleInfo><title>Vaginal immunization to elicit primary T‐cell activation and dissemination</title></titleInfo><name type="personal"><namePart type="given">E</namePart><namePart type="family">Pettini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Prota</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Ciabattini</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Boianelli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Fiorino</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Pozzi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Vicino</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Medaglini</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pettini E, Prota G, Ciabattini A, Boianelli A, Fiorino F, Pozzi G, Vicino A, Medaglini D. Vaginal immunization to elicit primary T‐cell activation and dissemination. PLoS One 2013, 8:e80545.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>e80545</start></extent></part><relatedItem type="host"><titleInfo><title>PLoS One</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>e80545</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0069"><titleInfo><title>Mucosal delivery of CpG oligodeoxynucleotides expands functional dendritic cells and macrophages in the vagina</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Sajic</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">Patrick</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KL</namePart><namePart type="family">Rosenthal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Sajic D, Patrick AJ, Rosenthal KL. Mucosal delivery of CpG oligodeoxynucleotides expands functional dendritic cells and macrophages in the vagina. Immunology 2005, 114:213–224.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>213</start><end>224</end></extent></part><relatedItem type="host"><titleInfo><title>Immunology</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>114</number></detail><extent unit="pages"><start>213</start><end>224</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0070"><titleInfo><title>Lipopeptide vaccines‐‐yesterday, today, and tomorrow</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">BenMohamed</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SL</namePart><namePart type="family">Wechsler</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AB</namePart><namePart type="family">Nesburn</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">BenMohamed L, Wechsler SL, Nesburn AB. Lipopeptide vaccines‐‐yesterday, today, and tomorrow. Lancet Infect Dis 2002, 2:425–431.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>425</start><end>431</end></extent></part><relatedItem type="host"><titleInfo><title>Lancet Infect Dis</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>425</start><end>431</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0071"><titleInfo><title>Th‐cytotoxic T‐lymphocyte chimeric epitopes extended by Nepsilon‐palmitoyl lysines induce herpes simplex virus type 1‐specific effector CD8+ Tc1 responses and protect against ocular infection</title></titleInfo><name type="personal"><namePart type="given">XIA</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EA</namePart><namePart type="family">Berg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JB</namePart><namePart type="family">Fishman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AB</namePart><namePart type="family">Nesburn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L</namePart><namePart type="family">BenMohamed</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zhang XIA, Berg EA, Fishman JB, Nesburn AB, BenMohamed L. Th‐cytotoxic T‐lymphocyte chimeric epitopes extended by Nepsilon‐palmitoyl lysines induce herpes simplex virus type 1‐specific effector CD8+ Tc1 responses and protect against ocular infection. J Virol 2005, 79:15289–15301.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>15289</start><end>15301</end></extent></part><relatedItem type="host"><titleInfo><title>J Virol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>79</number></detail><extent unit="pages"><start>15289</start><end>15301</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0072"><titleInfo><title>Mucosal adjuvants and delivery systems for protein‐ DNA‐ and RNA‐based vaccines</title></titleInfo><name type="personal"><namePart type="given">M</namePart><namePart type="family">Vajdy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I</namePart><namePart type="family">Srivastava</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Polo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Donnelly</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">O'Hagan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Singh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vajdy M, Srivastava I, Polo J, Donnelly J, O'Hagan D, Singh M. Mucosal adjuvants and delivery systems for protein‐ DNA‐ and RNA‐based vaccines. Immunol Cell Biol 2004, 82:617–627.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>82</number></detail><extent unit="pages"><start>617</start><end>627</end></extent></part><relatedItem type="host"><titleInfo><title>Immunol Cell Biol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>82</number></detail><extent unit="pages"><start>617</start><end>627</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0073"><titleInfo><title>Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens</title></titleInfo><name type="personal"><namePart type="given">F</namePart><namePart type="family">Wegmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">KH</namePart><namePart type="family">Gartlan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AM</namePart><namePart type="family">Harandi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SA</namePart><namePart type="family">Brinckmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Coccia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WR</namePart><namePart type="family">Hillson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WL</namePart><namePart type="family">Kok</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Cole</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LP</namePart><namePart type="family">Ho</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Lambe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wegmann F, Gartlan KH, Harandi AM, Brinckmann SA, Coccia M, Hillson WR, Kok WL, Cole S, Ho LP, Lambe T, et al. Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens. Nat Biotechnol 2012, 30:883–888.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>883</start><end>888</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Biotechnol</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>883</start><end>888</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0074"><titleInfo><title>Lipopeptide immunization without adjuvant induces potent and long‐lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">BenMohamed</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Gras‐Masse</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Tartar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Daubersies</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Brahimi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bossus</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Thomas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Druilhe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">BenMohamed L, Gras‐Masse H, Tartar A, Daubersies P, Brahimi K, Bossus M, Thomas A, Druilhe P. Lipopeptide immunization without adjuvant induces potent and long‐lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur J Immunol 1997, 27:1242–1253.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1242</start><end>1253</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Immunol</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>1242</start><end>1253</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0075"><titleInfo><title>Vaginal drug delivery systems for HIV prevention</title></titleInfo><name type="personal"><namePart type="given">LC</namePart><namePart type="family">Rohan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AB</namePart><namePart type="family">Sassi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rohan LC, Sassi AB. Vaginal drug delivery systems for HIV prevention. AAPS J 2009, 11:78–87.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>78</start><end>87</end></extent></part><relatedItem type="host"><titleInfo><title>AAPS J</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>78</start><end>87</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0076"><titleInfo><title>The scope and potential of vaginal drug delivery</title></titleInfo><name type="personal"><namePart type="given">K</namePart><namePart type="family">Vermani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Garg</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Vermani K, Garg S. The scope and potential of vaginal drug delivery. Pharm Sci Technolo Today 2000, 3:359–364.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>359</start><end>364</end></extent></part><relatedItem type="host"><titleInfo><title>Pharm Sci Technolo Today</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>359</start><end>364</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0077"><titleInfo><title>A neonatal Fc receptor‐targeted mucosal vaccine strategy effectively induces HIV‐1 antigen‐specific immunity to genital infection</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Lu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Palaniyandi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Zeng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Bai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Liu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CD</namePart><namePart type="family">Pauza</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DC</namePart><namePart type="family">Roopenian</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X</namePart><namePart type="family">Zhu</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lu L, Palaniyandi S, Zeng R, Bai Y, Liu X, Wang Y, Pauza CD, Roopenian DC, Zhu X. A neonatal Fc receptor‐targeted mucosal vaccine strategy effectively induces HIV‐1 antigen‐specific immunity to genital infection. J Virol 2011, 85:10542–10553.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>10542</start><end>10553</end></extent></part><relatedItem type="host"><titleInfo><title>J Virol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>10542</start><end>10553</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0078"><titleInfo><title>Genital delivery of virus‐like particle and pseudovirus‐based vaccines</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Cuburu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Chackerian</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cuburu N, Chackerian B. Genital delivery of virus‐like particle and pseudovirus‐based vaccines. Expert Rev Vaccines 2011, 10:1245–1248.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>1245</start><end>1248</end></extent></part><relatedItem type="host"><titleInfo><title>Expert Rev Vaccines</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>1245</start><end>1248</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0079"><titleInfo><title>Liposomes as vaccine delivery systems: a review of the recent advances</title></titleInfo><name type="personal"><namePart type="given">RA</namePart><namePart type="family">Schwendener</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schwendener RA. Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccines 2014, 2:159–182.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>159</start><end>182</end></extent></part><relatedItem type="host"><titleInfo><title>Ther Adv Vaccines</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>159</start><end>182</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0080"><titleInfo><title>Clinical development of liposome‐based drugs: formulation, characterization, and therapeutic efficacy</title></titleInfo><name type="personal"><namePart type="given">H‐I</namePart><namePart type="family">Chang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M‐K</namePart><namePart type="family">Yeh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chang H‐I, Yeh M‐K. Clinical development of liposome‐based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomedicine 2012, 7:49.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>49</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Nanomedicine</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>49</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0081"><titleInfo><title>Timeline: the rise and rise of drug delivery</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Rosen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Abribat</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Rosen H, Abribat T. Timeline: the rise and rise of drug delivery. Nat Rev Drug Discov 2005, 4:381–385.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>381</start><end>385</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Rev Drug Discov</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>381</start><end>385</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0082"><titleInfo><title>Nanoparticles in medicine: therapeutic applications and developments</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Zhang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">FX</namePart><namePart type="family">Gu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Chan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AZ</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RS</namePart><namePart type="family">Langer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">OC</namePart><namePart type="family">Farokhzad</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 2007, 83:761–769.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>761</start><end>769</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Pharmacol Ther</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>83</number></detail><extent unit="pages"><start>761</start><end>769</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0083"><titleInfo><title>Novel fusogenic liposomes for fluorescent cell labeling and membrane modification</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Csiszár</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Hersch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Dieluweit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Biehl</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Merkel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Hoffmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Csiszár A, Hersch N, Dieluweit S, Biehl R, Merkel R, Hoffmann B. Novel fusogenic liposomes for fluorescent cell labeling and membrane modification. Bioconjug Chem 2010, 21:537–543.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>537</start><end>543</end></extent></part><relatedItem type="host"><titleInfo><title>Bioconjug Chem</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>537</start><end>543</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0084"><titleInfo><title>Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Kunisawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Nakagawa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Mayumi</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kunisawa J, Nakagawa S, Mayumi T. Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development. Adv Drug Deliv Rev 2001, 52:177–186.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>177</start><end>186</end></extent></part><relatedItem type="host"><titleInfo><title>Adv Drug Deliv Rev</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>52</number></detail><extent unit="pages"><start>177</start><end>186</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0085"><titleInfo><title>Targeted polymeric therapeutic nanoparticles: design, development and clinical translation</title></titleInfo><name type="personal"><namePart type="given">N</namePart><namePart type="family">Kamaly</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Xiao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PM</namePart><namePart type="family">Valencia</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AF</namePart><namePart type="family">Radovic‐Moreno</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">OC</namePart><namePart type="family">Farokhzad</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kamaly N, Xiao Z, Valencia PM, Radovic‐Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 2012, 41:2971–3010.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>2971</start><end>3010</end></extent></part><relatedItem type="host"><titleInfo><title>Chem Soc Rev</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>41</number></detail><extent unit="pages"><start>2971</start><end>3010</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0086"><titleInfo><title>Interbilayer‐crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses</title></titleInfo><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Moon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Suh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bershteyn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MT</namePart><namePart type="family">Stephan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Liu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Huang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Sohail</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Luo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SH</namePart><namePart type="family">Um</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Khant</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Moon JJ, Suh H, Bershteyn A, Stephan MT, Liu H, Huang B, Sohail M, Luo S, Um SH, Khant H, et al. Interbilayer‐crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater 2011, 10:243–251.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>243</start><end>251</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Mater</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>243</start><end>251</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0087"><titleInfo><title>Generation of effector memory T cell‐based mucosal and systemic immunity with pulmonary nanoparticle vaccination</title></titleInfo><name type="personal"><namePart type="given">AV</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JJ</namePart><namePart type="family">Moon</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Abraham</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Suh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Elkhader</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Seidman</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Yen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">EJ</namePart><namePart type="family">Im</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MH</namePart><namePart type="family">Foley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DH</namePart><namePart type="family">Barouch</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Li AV, Moon JJ, Abraham W, Suh H, Elkhader J, Seidman MA, Yen M, Im EJ, Foley MH, Barouch DH, et al. Generation of effector memory T cell‐based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci Transl Med 2013, 5:204ra130.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>204ra130</start></extent></part><relatedItem type="host"><titleInfo><title>Sci Transl Med</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>204ra130</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0088"><titleInfo><title>pH‐sensitive Eudragit nanoparticles for mucosal drug delivery</title></titleInfo><name type="personal"><namePart type="given">J‐W</namePart><namePart type="family">Yoo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Giri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CH</namePart><namePart type="family">Lee</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Yoo J‐W, Giri N, Lee CH. pH‐sensitive Eudragit nanoparticles for mucosal drug delivery. Int J Pharm 2011, 403:262–267.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>403</number></detail><extent unit="pages"><start>262</start><end>267</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Pharm</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>403</number></detail><extent unit="pages"><start>262</start><end>267</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0089"><titleInfo><title>PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Stano</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AJ</namePart><namePart type="family">van der Vlies</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MM</namePart><namePart type="family">Martino</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MA</namePart><namePart type="family">Swartz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JA</namePart><namePart type="family">Hubbell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Simeoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Stano A, van der Vlies AJ, Martino MM, Swartz MA, Hubbell JA, Simeoni E. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration. Vaccine 2011, 29:804–812.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>804</start><end>812</end></extent></part><relatedItem type="host"><titleInfo><title>Vaccine</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>29</number></detail><extent unit="pages"><start>804</start><end>812</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0090"><titleInfo><title>Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2</title></titleInfo><name type="personal"><namePart type="given">Q</namePart><namePart type="family">He</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Mitchell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Morcol</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SJD</namePart><namePart type="family">Bell</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">He Q, Mitchell A, Morcol T, Bell SJD. Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2. Clin Diagn Lab Immunol 2002, 9:1021–1024.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1021</start><end>1024</end></extent></part><relatedItem type="host"><titleInfo><title>Clin Diagn Lab Immunol</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>1021</start><end>1024</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0091"><titleInfo><title>Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small‐interfering RNA</title></titleInfo><name type="personal"><namePart type="given">KA</namePart><namePart type="family">Woodrow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Cu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CJ</namePart><namePart type="family">Booth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JK</namePart><namePart type="family">Saucier‐Sawyer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MJ</namePart><namePart type="family">Wood</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WM</namePart><namePart type="family">Saltzman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Woodrow KA, Cu Y, Booth CJ, Saucier‐Sawyer JK, Wood MJ, Saltzman WM. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small‐interfering RNA. Nat Mater 2009, 8:526–533.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>526</start><end>533</end></extent></part><relatedItem type="host"><titleInfo><title>Nat Mater</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>8</number></detail><extent unit="pages"><start>526</start><end>533</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0092"><titleInfo><title>Targeted delivery of PSC‐RANTES for HIV‐1 prevention using biodegradable nanoparticles</title></titleInfo><name type="personal"><namePart type="given">AS</namePart><namePart type="family">Ham</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Cost</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AB</namePart><namePart type="family">Sassi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CS</namePart><namePart type="family">Dezzutti</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LC</namePart><namePart type="family">Rohan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ham AS, Cost MR, Sassi AB, Dezzutti CS, Rohan LC. Targeted delivery of PSC‐RANTES for HIV‐1 prevention using biodegradable nanoparticles. Pharm Res 2009, 26:502–511.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>502</start><end>511</end></extent></part><relatedItem type="host"><titleInfo><title>Pharm Res</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>502</start><end>511</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0093"><titleInfo><title>Mucoadhesive nanoparticulate systems for peptide drug delivery</title></titleInfo><name type="personal"><namePart type="given">H</namePart><namePart type="family">Takeuchi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Yamamoto</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Kawashima</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev 2001, 47:39–54.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>39</start><end>54</end></extent></part><relatedItem type="host"><titleInfo><title>Adv Drug Deliv Rev</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>39</start><end>54</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0094"><titleInfo><title>Mucoadhesive systems in oral drug delivery</title></titleInfo><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bernkop‐Schnürch</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Bernkop‐Schnürch A. Mucoadhesive systems in oral drug delivery. Drug Discov Today Technol 2005, 2:83–87.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>83</start><end>87</end></extent></part><relatedItem type="host"><titleInfo><title>Drug Discov Today Technol</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>83</start><end>87</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0095"><titleInfo><title>Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Meng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TF</namePart><namePart type="family">Sturgis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B‐BC</namePart><namePart type="family">Youan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Meng J, Sturgis TF, Youan B‐BC. Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion. Eur J Pharm Sci 2011, 44:57–67.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>57</start><end>67</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Pharm Sci</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>57</start><end>67</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0096"><titleInfo><title>Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Dünnhaupt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Barthelmes</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Hombach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Sakloetsakun</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Arkhipova</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Bernkop‐Schnürch</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Dünnhaupt S, Barthelmes J, Hombach J, Sakloetsakun D, Arkhipova V, Bernkop‐Schnürch A. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa. Int J Pharm 2011, 408:191–199.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>408</number></detail><extent unit="pages"><start>191</start><end>199</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Pharm</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>408</number></detail><extent unit="pages"><start>191</start><end>199</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0097"><titleInfo><title>In vivo distribution of surface‐modified PLGA nanoparticles following intravaginal delivery</title></titleInfo><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Cu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CJ</namePart><namePart type="family">Booth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">WM</namePart><namePart type="family">Saltzman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cu Y, Booth CJ, Saltzman WM. In vivo distribution of surface‐modified PLGA nanoparticles following intravaginal delivery. J Control Release 2011, 156:258–264.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>156</number></detail><extent unit="pages"><start>258</start><end>264</end></extent></part><relatedItem type="host"><titleInfo><title>J Control Release</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>156</number></detail><extent unit="pages"><start>258</start><end>264</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0098"><titleInfo><title>Mucus‐penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus</title></titleInfo><name type="personal"><namePart type="given">LM</namePart><namePart type="family">Ensign</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">BC</namePart><namePart type="family">Tang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">YY</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TA</namePart><namePart type="family">Tse</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Hoen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Cone</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Hanes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ensign LM, Tang BC, Wang YY, Tse TA, Hoen T, Cone R, Hanes J. Mucus‐penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med 2012, 4:138ra79.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>138ra79</start></extent></part><relatedItem type="host"><titleInfo><title>Sci Transl Med</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>138ra79</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0099"><titleInfo><title>Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that ‘slip’ through the human mucus barrier</title></titleInfo><name type="personal"><namePart type="given">Y‐Y</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SK</namePart><namePart type="family">Lai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JS</namePart><namePart type="family">Suk</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Pace</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Cone</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Hanes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wang Y‐Y, Lai SK, Suk JS, Pace A, Cone R, Hanes J. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that ‘slip’ through the human mucus barrier. Angew Chem Int Ed Engl 2008, 47:9726–9729.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>9726</start><end>9729</end></extent></part><relatedItem type="host"><titleInfo><title>Angew Chem Int Ed Engl</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>47</number></detail><extent unit="pages"><start>9726</start><end>9729</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0100"><titleInfo><title>Mucus‐penetrating nanoparticles for drug and gene delivery to mucosal tissues</title></titleInfo><name type="personal"><namePart type="given">SK</namePart><namePart type="family">Lai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y‐Y</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Hanes</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lai SK, Wang Y‐Y, Hanes J. Mucus‐penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009, 61:158–171.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>61</number></detail><extent unit="pages"><start>158</start><end>171</end></extent></part><relatedItem type="host"><titleInfo><title>Adv Drug Deliv Rev</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>61</number></detail><extent unit="pages"><start>158</start><end>171</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0101"><titleInfo><title>Nanoparticle PEGylation for imaging and therapy</title></titleInfo><name type="personal"><namePart type="given">JV</namePart><namePart type="family">Jokerst</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Lobovkina</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RN</namePart><namePart type="family">Zare</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SS</namePart><namePart type="family">Gambhir</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jokerst JV, Lobovkina T, Zare RN, Gambhir SS. Nanoparticle PEGylation for imaging and therapy. Nanomedicine 2011, 6:715–728.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>715</start><end>728</end></extent></part><relatedItem type="host"><titleInfo><title>Nanomedicine</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>715</start><end>728</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0102"><titleInfo><title>Pegylation of poly (γ‐benzyl‐L‐glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats</title></titleInfo><name type="personal"><namePart type="given">I</namePart><namePart type="family">Özcan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Segura‐Sánchez</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Bouchemal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Sezak</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O</namePart><namePart type="family">Ozer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Güneri</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G</namePart><namePart type="family">Ponchel</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Özcan I, Segura‐Sánchez F, Bouchemal K, Sezak M, Ozer O, Güneri T, Ponchel G. Pegylation of poly (γ‐benzyl‐L‐glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats. Int J Nanomedicine 2010, 5:1103.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>1103</start></extent></part><relatedItem type="host"><titleInfo><title>Int J Nanomedicine</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>1103</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0103"><titleInfo><title>Transferrin conjugation confers mucosal molecular targeting to a model HIV‐1 trimeric gp140 vaccine antigen</title></titleInfo><name type="personal"><namePart type="given">JFS</namePart><namePart type="family">Mann</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Stieh</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Klein</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DS</namePart><namePart type="family">de Stegmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MP</namePart><namePart type="family">Cranage</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RJ</namePart><namePart type="family">Shattock</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PF</namePart><namePart type="family">McKay</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mann JFS, Stieh D, Klein K, de Stegmann DS, Cranage MP, Shattock RJ, McKay PF. Transferrin conjugation confers mucosal molecular targeting to a model HIV‐1 trimeric gp140 vaccine antigen. J Control Release 2012, 158:240–249.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>240</start><end>249</end></extent></part><relatedItem type="host"><titleInfo><title>J Control Release</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>158</number></detail><extent unit="pages"><start>240</start><end>249</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0104"><titleInfo><title>Characterization of endocytosis of transferrin‐coated PLGA nanoparticles by the blood–brain barrier</title></titleInfo><name type="personal"><namePart type="given">J</namePart><namePart type="family">Chang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y</namePart><namePart type="family">Jallouli</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Kroubi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">XB</namePart><namePart type="family">Yuan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W</namePart><namePart type="family">Feng</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CS</namePart><namePart type="family">Kang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PY</namePart><namePart type="family">Pu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Betbeder</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Chang J, Jallouli Y, Kroubi M, Yuan XB, Feng W, Kang CS, Pu PY, Betbeder D. Characterization of endocytosis of transferrin‐coated PLGA nanoparticles by the blood–brain barrier. Int J Pharm 2009, 379:285–292.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>379</number></detail><extent unit="pages"><start>285</start><end>292</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Pharm</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>379</number></detail><extent unit="pages"><start>285</start><end>292</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0105"><titleInfo><title>Transcytosis and brain uptake of transferrin‐containing nanoparticles by tuning avidity to transferrin receptor</title></titleInfo><name type="personal"><namePart type="given">DT</namePart><namePart type="family">Wiley</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Webster</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Gale</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ME</namePart><namePart type="family">Davis</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wiley DT, Webster P, Gale A, Davis ME. Transcytosis and brain uptake of transferrin‐containing nanoparticles by tuning avidity to transferrin receptor. Proc Natl Acad Sci USA 2013, 110:8662–8667.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>8662</start><end>8667</end></extent></part><relatedItem type="host"><titleInfo><title>Proc Natl Acad Sci USA</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>110</number></detail><extent unit="pages"><start>8662</start><end>8667</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0106"><titleInfo><title>Transepithelial transport of Fc‐targeted nanoparticles by the neonatal Fc receptor for oral delivery</title></titleInfo><name type="personal"><namePart type="given">EM</namePart><namePart type="family">Pridgen</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Alexis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">TT</namePart><namePart type="family">Kuo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Levy‐Nissenbaum</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Karnik</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RS</namePart><namePart type="family">Blumberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Langer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">OC</namePart><namePart type="family">Farokhzad</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Pridgen EM, Alexis F, Kuo TT, Levy‐Nissenbaum E, Karnik R, Blumberg RS, Langer R, Farokhzad OC. Transepithelial transport of Fc‐targeted nanoparticles by the neonatal Fc receptor for oral delivery. Sci Transl Med 2013, 5:213ra167.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>213ra167</start></extent></part><relatedItem type="host"><titleInfo><title>Sci Transl Med</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>213ra167</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0107"><titleInfo><title>Neonatal Fc receptor: from immunity to therapeutics</title></titleInfo><name type="personal"><namePart type="given">TT</namePart><namePart type="family">Kuo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Baker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Yoshida</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SW</namePart><namePart type="family">Qiao</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Kuo TT, Baker K, Yoshida M, Qiao SW. Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol 2010, 30:777–789.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>777</start><end>789</end></extent></part><relatedItem type="host"><titleInfo><title>J Clin Immunol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><extent unit="pages"><start>777</start><end>789</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0108"><titleInfo><title>Nanoparticles target distinct dendritic cell populations according to their size</title></titleInfo><name type="personal"><namePart type="given">V</namePart><namePart type="family">Manolova</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Flace</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Bauer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Schwarz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Saudan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MF</namePart><namePart type="family">Bachmann</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008, 38:1404–1413.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>1404</start><end>1413</end></extent></part><relatedItem type="host"><titleInfo><title>Eur J Immunol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>38</number></detail><extent unit="pages"><start>1404</start><end>1413</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0109"><titleInfo><title>Nanoparticle vaccines</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Zhao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Seth</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Wibowo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CX</namePart><namePart type="family">Zhao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N</namePart><namePart type="family">Mitter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C</namePart><namePart type="family">Yu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">AP</namePart><namePart type="family">Middelberg</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, Middelberg AP. Nanoparticle vaccines. Vaccine 2014, 32:327–337.</note><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>327</start><end>337</end></extent></part><relatedItem type="host"><titleInfo><title>Vaccine</title></titleInfo><part><date>2014</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>327</start><end>337</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0110"><titleInfo><title>Size‐dependent immunogenicity: therapeutic and protective properties of nano‐vaccines against tumors</title></titleInfo><name type="personal"><namePart type="given">GA</namePart><namePart type="family">FifisT</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Crimeen‐Irwin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">GA</namePart><namePart type="family">Pietersz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Li</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PL</namePart><namePart type="family">Mottram</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">IF</namePart><namePart type="family">McKenzie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Plebanski</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">FifisT GA, Crimeen‐Irwin B, Pietersz GA, Li J, Mottram PL, McKenzie IF, Plebanski M. Size‐dependent immunogenicity: therapeutic and protective properties of nano‐vaccines against tumors. J Immunol 2004, 173:3148–3154.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>173</number></detail><extent unit="pages"><start>3148</start><end>3154</end></extent></part><relatedItem type="host"><titleInfo><title>J Immunol</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>173</number></detail><extent unit="pages"><start>3148</start><end>3154</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0111"><titleInfo><title>Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints</title></titleInfo><name type="personal"><namePart type="given">CL</namePart><namePart type="family">Hardy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JS</namePart><namePart type="family">Lemasurier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Mohamud</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Yao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">SD</namePart><namePart type="family">Xiang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">JM</namePart><namePart type="family">Rolland</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RE</namePart><namePart type="family">O'Hehir</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M</namePart><namePart type="family">Plebanski</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hardy CL, Lemasurier JS, Mohamud R, Yao J, Xiang SD, Rolland JM, O'Hehir RE, Plebanski M. Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints. J Immunol 2013, 191:5278–5290.</note><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>191</number></detail><extent unit="pages"><start>5278</start><end>5290</end></extent></part><relatedItem type="host"><titleInfo><title>J Immunol</title></titleInfo><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>191</number></detail><extent unit="pages"><start>5278</start><end>5290</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0112"><titleInfo><title>Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model</title></titleInfo><name type="personal"><namePart type="given">C</namePart><namePart type="family">Foged</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Brodin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Frokjaer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Sundblad</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 2005, 298:315–322.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>298</number></detail><extent unit="pages"><start>315</start><end>322</end></extent></part><relatedItem type="host"><titleInfo><title>Int J Pharm</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>298</number></detail><extent unit="pages"><start>315</start><end>322</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0113"><titleInfo><title>Evaluation of particle uptake in human blood monocyte‐derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?</title></titleInfo><name type="personal"><namePart type="given">L</namePart><namePart type="family">Thiele</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Rothen‐Rutishauser</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Jilek</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Wunderli‐Allenspach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">HP</namePart><namePart type="family">Merkle</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Walter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Thiele L, Rothen‐Rutishauser B, Jilek S, Wunderli‐Allenspach H, Merkle HP, Walter E. Evaluation of particle uptake in human blood monocyte‐derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J Control Release 2001, 76:59–71.</note><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>76</number></detail><extent unit="pages"><start>59</start><end>71</end></extent></part><relatedItem type="host"><titleInfo><title>J Control Release</title></titleInfo><part><date>2001</date><detail type="volume"><caption>vol.</caption><number>76</number></detail><extent unit="pages"><start>59</start><end>71</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0114"><titleInfo><title>Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein</title></titleInfo><name type="personal"><namePart type="given">D</namePart><namePart type="family">Raghuwanshi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V</namePart><namePart type="family">Mishra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Das</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K</namePart><namePart type="family">Kaur</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MR</namePart><namePart type="family">Suresh</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Raghuwanshi D, Mishra V, Das D, Kaur K, Suresh MR. Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein. Mol Pharm 2012, 9:946–956.</note><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>946</start><end>956</end></extent></part><relatedItem type="host"><titleInfo><title>Mol Pharm</title></titleInfo><part><date>2012</date><detail type="volume"><caption>vol.</caption><number>9</number></detail><extent unit="pages"><start>946</start><end>956</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0115"><titleInfo><title>Targeted PLGA nano‐but not microparticles specifically deliver antigen to human dendritic cells via DC‐SIGN in vitro</title></titleInfo><name type="personal"><namePart type="given">LJ</namePart><namePart type="family">Cruz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">PJ</namePart><namePart type="family">Tacken</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Fokkink</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Joosten</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">MC</namePart><namePart type="family">Stuart</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F</namePart><namePart type="family">Albericio</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R</namePart><namePart type="family">Torensma</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CG</namePart><namePart type="family">Figdor</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cruz LJ, Tacken PJ, Fokkink R, Joosten B, Stuart MC, Albericio F, Torensma R, Figdor CG. Targeted PLGA nano‐but not microparticles specifically deliver antigen to human dendritic cells via DC‐SIGN in vitro. J Control Release 2010, 144:118–126.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>144</number></detail><extent unit="pages"><start>118</start><end>126</end></extent></part><relatedItem type="host"><titleInfo><title>J Control Release</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>144</number></detail><extent unit="pages"><start>118</start><end>126</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="wnan1359-cit-0116"><titleInfo><title>Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments</title></titleInfo><name type="personal"><namePart type="given">W</namePart><namePart type="family">Mi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Wanjie</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ST</namePart><namePart type="family">Lo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Gan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Pickl‐Herk</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RJ</namePart><namePart type="family">Ober</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">ES</namePart><namePart type="family">Ward</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mi W, Wanjie S, Lo ST, Gan Z, Pickl‐Herk B, Ober RJ, Ward ES. Targeting the neonatal fc receptor for antigen delivery using engineered fc fragments. J Immunol 2008, 181:7550–7561.</note><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>181</number></detail><extent unit="pages"><start>7550</start><end>7561</end></extent></part><relatedItem type="host"><titleInfo><title>J Immunol</title></titleInfo><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>181</number></detail><extent unit="pages"><start>7550</start><end>7561</end></extent></part></relatedItem></relatedItem><identifier type="istex">72A9720C0E2D5A684AC4D6A6A7B7A7FB8DC701DE</identifier><identifier type="ark">ark:/67375/WNG-QT8G269T-H</identifier><identifier type="DOI">10.1002/wnan.1359</identifier><identifier type="ArticleID">WNAN1359</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2016 Wiley Periodicals, Inc.© 2015 Wiley Periodicals, Inc.</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-16</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-QT8G269T-H/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D28 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001D28 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:72A9720C0E2D5A684AC4D6A6A7B7A7FB8DC701DE
|texte= Engineering immunity in the mucosal niche against sexually transmitted infections
}}
| This area was generated with Dilib version V0.6.33. |  |